County
Anderson County Emergency Medical Services
Anderson County Emergency Medical Services (TN) carries 53 drugs across 218 dose entries in its current published protocol, effective 2026-02-01.
Drugs and doses53
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | page 14 |
| Fever | adult | 500 mg | PO | not captured | standing | page 14 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | page 14 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 14 |
| Other | adult | 1000 mg | IV | not captured | standing | page 16 |
| Other | adult | 500 mg | PO | not captured | standing | page 16 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 16 |
| Other | peds | 15 mg/kg | PO | not captured | standing | page 16 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 24 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 24 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | page 49 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 49 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–7.5 mg | not captured | not captured | standing | page 10 |
| Asthma / bronchospasm | peds | 2.5–7.5 mg | not captured | not captured | standing | page 10 |
| Hyperkalemia | adult | 10 mg | not captured | not captured | standing | page 46 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 39 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV/IO | not captured | standing | page 41 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 41 |
| Organophosphate poisoning | adult | 2 mg | IV | not captured | standing | page 35 |
| Organophosphate poisoning | adult | 2 mg | IM | not captured | standing | page 35 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 35 |
| Organophosphate poisoning | peds | 1 mg | IM | not captured | standing | page 35 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 10–20 mL | IV/IO | not captured | standing | page 46 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 46 |
| Obstetric hemorrhage | adult | 1 g | not captured | not captured | standing | page 21 |
| Other | adult | 1–2 g | IV | not captured | standing | page 23 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 23 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 46 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | page 46 |
| Obstetric hemorrhage | adult | 1 g | not captured | not captured | standing | page 21 |
| Other | adult | 1–2 g | IV | not captured | standing | page 23 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 23 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 137 |
| Trauma / hemorrhage | peds | 1 g | IV | not captured | standing | page 137 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 4–8 mg | IV | not captured | standing | page 137 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 15 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 15 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 5–20 mg | IV/IO | not captured | standing | page 27 |
| Seizure | adult | 5–20 mg | IM | not captured | standing | page 27 |
| Seizure | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 27 |
| Seizure | peds | 0.1–0.3 mg/kg | IM | not captured | standing | page 27 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 49 |
| SVT | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 49 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 10 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 10 |
| Dystonic reaction | adult | 50 mg | IV/IM | not captured | standing | page 23 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 23 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 1–20 mcg/kg | IV | not captured | standing | page 139 |
| Cardiogenic shock | peds | 1–20 mcg/kg | IV | not captured | standing | page 139 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 10 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 10 |
| Asthma / bronchospasm | adult | 0.5 mg | IM | not captured | standing | page 22 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 22 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 40 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 40 |
| Hypotension / shock | adult | 0.5–2 mL | IV | not captured | standing | page 17 |
| Hypotension / shock | peds | 1 mcg/kg | IV | not captured | standing | page 17 |
| Neonatal resuscitation | peds | 0.01–0.03 mg/kg | IV/IO | not captured | standing | page 47 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 7 |
| RSI induction | peds | 0.3 mg/kg | IV | not captured | standing | page 7 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 39 |
| Mild to moderate pain | adult | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 24 |
| Mild to moderate pain | peds | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 24 |
| Post-intubation sedation | adult | 2 mcg/kg | IV | not captured | standing | page 7 |
| Post-intubation sedation | peds | 2 mcg/kg | IV | not captured | standing | page 7 |
| RSI induction | adult | 2 mcg/kg | IV | not captured | standing | page 7 |
| RSI induction | peds | 2 mcg/kg | IV | not captured | standing | page 7 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–80 mg | IV | not captured | standing | page 141 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 141 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 142 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 60 unit/kg | IV | not captured | standing | page 142 |
| STEMI | adult | 60 unit/kg | IV | not captured | standing | page 142 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV/IM | not captured | standing | page 143 |
| Other | peds | 0.25 mg/kg | IV/IM | not captured | standing | page 143 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 800 mg | PO | not captured | standing | page 14 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 14 |
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | page 143 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 143 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 22 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 22 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO/IN | not captured | standing | page 36 |
| Agitation | adult | 2 mg/kg | IM | not captured | standing | page 36 |
| Agitation | adult | 2 mg/kg | IV/IO/IN | not captured | standing | page 36 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 36 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 24 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 24 |
| Post-intubation sedation | adult | 1–2 mg/kg | IV | not captured | standing | page 7 |
| Post-intubation sedation | peds | 1–2 mg/kg | IV | not captured | standing | page 7 |
| RSI induction | adult | 1.5–2 mg/kg | IV/IO | not captured | standing | page 7 |
| RSI induction | peds | 1.5–2 mg/kg | IV/IO | not captured | standing | page 7 |
| Seizure | adult | 1 mg/kg | IV/IO/IM/IN | not captured | standing | page 27 |
| Seizure | peds | 1 mg/kg | IV/IO/IM/IN | not captured | standing | page 27 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 30 mg | IV | not captured | standing | page 16 |
| Other | adult | 60 mg | IM | not captured | standing | page 16 |
| Mild to moderate pain | adult | 30 mg | IV | not captured | standing | page 24 |
| Mild to moderate pain | adult | 60 mg | IM | not captured | standing | page 24 |
| Severe pain | adult | 15–30 mg | IV/IO | not captured | standing | page 145 |
| Severe pain | adult | 30–60 mg | IM | not captured | standing | page 145 |
| Severe pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 145 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 145 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 11 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 11 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 51 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 51 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–2 mg | IV | not captured | standing | page 147 |
| Agitation | adult | 0.5–2 mg | IM | not captured | standing | page 147 |
| Status epilepticus | peds | 0.1 mg/kg | IV | not captured | standing | page 147 |
| Status epilepticus | peds | 0.1 mg/kg | IM | not captured | standing | page 147 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 22 |
| Asthma / bronchospasm | peds | 2 g | IV | not captured | standing | page 22 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 21 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 51 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 51 |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 g/kg | IV | not captured | standing | page 148 |
| Other | adult | 0.5 g/kg | IV | not captured | standing | page 148 |
| Other | peds | 0.25 g/kg | IV | not captured | standing | page 148 |
| Other | peds | 0.25 g/kg | IV | not captured | standing | page 148 |
Meperidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–50 mg | IV | not captured | standing | page 149 |
| Mild to moderate pain | adult | 50–100 mg | IM | not captured | standing | page 149 |
| Mild to moderate pain | peds | 1–1.8 mg/kg | IV | not captured | standing | page 149 |
| Mild to moderate pain | peds | 1–1.8 mg/kg | IM | not captured | standing | page 149 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 10 |
| Anaphylaxis | peds | 2 mg/kg | IV | not captured | standing | page 10 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 22 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | page 22 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 6 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 6 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–10 mg | IV/IN | not captured | standing | page 36 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 36 |
| Agitation | peds | 0.05–0.2 mg/kg | IM | not captured | standing | page 36 |
| Agitation | peds | 0.05–0.2 mg/kg | IV/IN | not captured | standing | page 36 |
| Bradycardia | adult | 2.5–10 mg | IV | not captured | standing | page 41 |
| Bradycardia | adult | 5 mg | IM | not captured | standing | page 41 |
| CHF / pulmonary edema | adult | 2.5–10 mg | IV | not captured | standing | page 44 |
| Post-intubation sedation | adult | 2.5–10 mg | IV | not captured | standing | page 7 |
| Post-intubation sedation | peds | 0.05–0.2 mg/kg | IV | not captured | standing | page 7 |
| RSI induction | adult | 5–10 mg | IV | not captured | standing | page 7 |
| RSI induction | peds | 0.2–0.4 mg/kg | IV | not captured | standing | page 7 |
| Seizure | adult | 2.5–10 mg | IV | not captured | standing | page 27 |
| Seizure | adult | 5–10 mg | IM/IN | not captured | standing | page 27 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 27 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | page 27 |
| Wide-complex tachycardia | adult | 2.5–10 mg | IV | not captured | standing | page 52 |
| Wide-complex tachycardia | peds | 0.05–0.2 mg/kg | IV | not captured | standing | page 52 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–20 mg | IV | not captured | standing | page 39 |
| Mild to moderate pain | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 24 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 24 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IN | not captured | standing | page 23 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 23 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 23 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 39 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 44 |
Nitrous Oxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50/50 mixture | NEB | not captured | standing | page 151 |
| ACS / chest pain | peds | 50/50 mixture | NEB | not captured | standing | page 151 |
| Burns | adult | 50/50 mixture | NEB | not captured | standing | page 151 |
| Burns | peds | 50/50 mixture | NEB | not captured | standing | page 151 |
| Mild to moderate pain | adult | 50/50 mixture | NEB | not captured | standing | page 151 |
| Mild to moderate pain | peds | 50/50 mixture | NEB | not captured | standing | page 151 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2–12 mcg | IV | not captured | standing | page 17 |
| Cardiac arrest | peds | 2–12 mcg | IV | not captured | standing | page 17 |
| Hypotension / shock | adult | 2–12 mcg | IV | not captured | standing | page 17 |
| Hypotension / shock | peds | 2–12 mcg | IV | not captured | standing | page 17 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 19 |
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | page 19 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV | not captured | standing | page 19 |
| Nausea / vomiting | peds | 2–4 mg | PO | not captured | standing | page 19 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 15 |
| Hypoglycemia | peds | 7.5 g | PO | not captured | standing | page 15 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 153 |
Phenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15–20 mg/kg | IV | not captured | standing | page 154 |
| Other | peds | 15–20 mg/kg | IV | not captured | standing | page 154 |
| Seizure | adult | 15–20 mg/kg | IV | not captured | standing | page 154 |
| Seizure | peds | 15–20 mg/kg | IV | not captured | standing | page 154 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | page 35 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 20 mg | IV | not captured | standing | page 154 |
| Wide-complex tachycardia | peds | 15 mg/kg | IV | not captured | standing | page 154 |
| VF / pulseless VT | adult | 20 mg | IV | not captured | standing | page 154 |
| VF / pulseless VT | peds | 15 mg/kg | IV | not captured | standing | page 154 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 16 |
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 19 |
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 19 |
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 19 |
| Nausea / vomiting | peds | 0.25 mg/kg | IM | not captured | standing | page 16 |
| Nausea / vomiting | peds | 0.25 mg/kg | IM | not captured | standing | page 19 |
| Nausea / vomiting | peds | 0.25 mg/kg | IM | not captured | standing | page 19 |
| Nausea / vomiting | peds | 0.25 mg/kg | IM | not captured | standing | page 19 |
| Other | adult | 12.5 mg | IM | not captured | standing | page 16 |
| Other | adult | 12.5 mg | IM | not captured | standing | page 19 |
| Other | peds | 0.25 mg/kg | IM | not captured | standing | page 19 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 30 mg | IV | not captured | standing | page 74 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 11.25 mg | NEB | not captured | standing | page 22 |
| Asthma / bronchospasm | peds | 11.25 mg | NEB | not captured | standing | page 22 |
| Croup | adult | 11.25 mg | NEB | not captured | standing | page 22 |
| Croup | peds | 11.25 mg | NEB | not captured | standing | page 22 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–1.5 mg/kg | IV | not captured | standing | page 7 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | page 7 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 46 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 46 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 60 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 60 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 23 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 23 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 156 |
| RSI induction | adult | 1–1.5 mg/kg | IV | not captured | standing | page 156 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Alcohol withdrawal | adult | 100 mg | IV/IO/IM | not captured | standing | page 157 |
| Alcohol withdrawal | peds | 100 mg | IV/IO/IM | not captured | standing | page 157 |
| Other | adult | 100 mg | IV/IO/IM | not captured | standing | page 157 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 21 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 65 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 65 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1–0.15 mg/kg | IV | not captured | standing | page 7 |
| RSI induction | peds | 0.1 mg/kg | IV | not captured | standing | page 7 |